Mitchell Mcleod Pugh & Williams Inc Abbott Laboratories Transaction History

Mitchell Mcleod Pugh & Williams Inc

$436 Million
Q2 2024

A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 8,159 shares of ABT stock, worth $927,188. This represents 0.19% of its overall portfolio holdings.

Number of Shares

8,159

Previous 8,204 0.55%

Holding current value

$927,188

Previous $932,000 9.12%

% of portfolio

0.19%

Previous 0.23%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $4,532 - $5,059	-45 Reduced 0.55%	8,159 $847,000
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $23,218 - $25,643	-212 Reduced 2.52%	8,204 $932,000
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $7,125 - $8,721	-79 Reduced 0.93%	8,416 $926,000
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $38,976 - $46,764	-408 Reduced 4.58%	8,495 $822,000
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $3,124 - $3,480	-31 Reduced 0.35%	8,903 $970,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $1,743 - $2,052	-18 Reduced 0.2%	8,934 $904,000
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $53,708 - $63,008	-565 Reduced 5.94%	8,952 $983,000
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $24,383 - $28,231	252 Added 2.72%	9,517 $921,000
Q2 2022 Nov 18, 2022	SELL	$102.07 - $123.37 $25,721 - $31,089	-252 Reduced 2.65%	9,265 $1.01 Million
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $45,608 - $55,616	400 Added 4.51%	9,265 $1.1 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $1,732 - $2,121	-15 Reduced 0.17%	8,865 $1.25 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $5,224 - $6,155	48 Added 0.54%	8,880 $1.06 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $17,010 - $18,536	162 Added 1.87%	8,832 $967,000
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $65,064 - $79,015	710 Added 8.92%	8,670 $944,000
Q2 2020 Jul 17, 2020	BUY	$76.57 - $98.0 $108,193 - $138,474	1,413 Added 21.58%	7,960 $728,000
Q1 2020 Apr 08, 2020	SELL	$62.82 - $91.86 $25,128 - $36,744	-400 Reduced 5.76%	6,547 $516,000
Q4 2019 Jan 08, 2020	SELL	$78.51 - $87.4 $12,169 - $13,547	-155 Reduced 2.18%	6,947 $603,000
Q3 2019 Oct 08, 2019	BUY	$81.84 - $88.74 $27,252 - $29,550	333 Added 4.92%	7,102 $594,000
Q3 2018 Oct 09, 2018	SELL	$60.81 - $73.36 $12,162 - $14,672	-200 Reduced 2.87%	6,769 $497,000
Q1 2018 Apr 16, 2018	SELL	$56.27 - $63.62 $11,254 - $12,724	-200 Reduced 2.79%	6,969 $417,000
Q4 2017 Jan 12, 2018	SELL	$53.68 - $57.47 $4,831 - $5,172	-90 Reduced 1.24%	7,169 $409,000
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $348,867 - $389,372	7,259	7,259 $387,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Account

Mitchell Mcleod Pugh & Williams Inc Abbott Laboratories Transaction History